Ferrer, a pharmaceutical corporation and CataloniaBio & HealthTech member, announced that Indian start-up Wellthy Therapeutics is the winner of the Ferrer 4 Future open innovation programme. The challenge included showcasing 65 start-ups from all over the world.
The two companies will sign a partnership agreement to develop a tool to help improve care for chronic patients.
The Ferrer 4 Future programme was launched by the company in November 2019. "Innovation and digital health solutions are key to finding new ways of improving patients’ clinical outcomes and quality across the patient care value chain. That is why we created Ferrer 4 Future, our first-ever open innovation programme launched by the company, as an active step towards collaborating with technology innovators," explains Ferrer’ Director of Digital Health and Technology Gemma Estrada.
"Personalised real-time care for every patient is the future of healthcare, and real-world outcomes are the new gold standard. We are excited to win the Ferrer 4 Future challenge" says Abhishek Shah, co-founder and CEO of Wellthy Therapeutics.
Established in Barcelona in 1959, Ferrer is currently present in more than one hundred countries and has a team of 2,000 people.
Comments